Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.
CAVA delivered 22.1% revenue growth and reached 500 restaurants, though margins faced pressure from labor investments and third-party delivery mix despite positive traffic and strong new unit productivity.
STAAR Surgical delivered record nine-month revenue driven by a structural shift from lasers to lenses, though supply constraints in China and temporary margin pressures from ERP implementation impacted the quarter.
Caris Life Sciences delivered record Q3 2026 revenue of $275.4M, up 27%, while raising full-year guidance and expanding its oncology platform into monitoring and MRD markets.
Figma delivered a strong Q3 beat with 43% revenue growth, driven by AI monetization and high net dollar retention, while aggressively investing in first-party models and its 'full stack canvas' strategy.
Aspen Neuroscience Insider Peter A. Thompson Buys $15M of Stock
Peter A. Thompson bought 1,000,000 shares of Aspen Neuroscience, Inc. at $15.00 a share, worth $15M in total on Nov 2, 2026. Shares held after the trade: 3,589,132 (+38.6%).
Aspen Neuroscience Insider Orbimed Advisors LLC Buys $15M of Stock
Orbimed Advisors LLC bought 1,000,000 shares of Aspen Neuroscience, Inc. at $15.00 a share, worth $15M in total on Nov 2, 2026. Shares held after the trade: 3,589,132 (+38.6%).
TKO delivered a strong beat-and-raise quarter driven by record UFC performance and accelerating WWE partnership revenue despite event timing headwinds.
Joby Aviation is transitioning from development to early operations, leveraging a strong $2.2 billion balance sheet and the strategic acquisition of Resonance Sciences to scale defense and autonomy.
Rubrik CTO Arvind Nithrakashyap Sells $4.51M of Stock
Arvind Nithrakashyap, CTO, sold 38,460 shares of Rubrik, Inc. at $114.17 to $122.42 a share (average $117.39) in 21 transactions, worth $4.51M in total between Nov 2, 2026 and Nov 4, 2026. Shares held after the trade: 272,538 (-0.1%).
Arcutis Biotherapeutics EVP, CLO Masaru Matsuda Sells $1.41M of Stock
Masaru Matsuda, EVP, CLO, sold 41,219 shares of Arcutis Biotherapeutics, Inc. at $31.86 to $34.32 a share (average $34.24) in 2 transactions, worth $1.41M in total between Nov 2, 2026 and Nov 4, 2026. Shares held after the trade: 111,289 (-26.4%).
Arcutis Biotherapeutics EVP, CMO Patrick Burnett Sells $30K of Stock
Patrick Burnett, EVP, CMO, sold 943 shares of Arcutis Biotherapeutics, Inc. at $31.86 a share, worth $30K in total on Nov 2, 2026. Shares held after the trade: 116,649 (-0.8%).
Arcutis Biotherapeutics Insider Todd Watanabe Sells $139K of Stock
Todd Watanabe sold 4,377 shares of Arcutis Biotherapeutics, Inc. at $31.86 a share, worth $139K in total on Nov 2, 2026. Shares held after the trade: 712,826 (-0.6%).
Meta Platforms COO Javier Olivan Sells $967K of Stock
Javier Olivan, COO, sold 1,575 shares of Meta Platforms, Inc. at $614.15 a share, worth $967K in total on Nov 2, 2026. Shares held after the trade: 74,989 (-0.5%).
Jazz Pharmaceuticals Insider Bruce C. Cozadd Sells $1.3M of Stock
Bruce C. Cozadd sold 6,000 shares of Jazz Pharmaceuticals plc at $215.84 a share, worth $1.3M in total on Nov 2, 2026. Shares held after the trade: 339,875 (-1.7%).
Veracyte delivered a Q3 revenue beat but significantly lowered Decipher prostate volume expectations, signaling a transition from outsized guideline-driven growth to a normalized, more competitive market environment.
David A. Hyman, CLO, sold 5,727 shares of Netflix Inc at $64.55 a share, worth $370K in total on Nov 4, 2026. Shares held after the trade: 166,100 (-3.3%).
Alto Ingredients delivered its fifth consecutive quarter of positive EBITDA, driven by healthy crush margins and 45Z tax credits, while pivoting sales to domestic markets to optimize economics over lower-margin European exports.
Sezzle delivered a strong Q3 with 42.6% revenue growth and significant margin expansion, driven by AI-led operational efficiencies and a successful shift toward a subscription-based 'Costco' model.
Lumen is pivoting from legacy copper to a digital-first platform, leveraging AI-driven demand and $13.5 billion in PCF deals to drive strategic revenue growth despite overall revenue declines.
PennyMac Mortgage Investment Trust CAO Gregory L. Hendry Sells $18.9K of Stock
Gregory L. Hendry, CAO, sold 2,443 shares of PennyMac Mortgage Investment Trust at $7.73 a share, worth $18.9K in total on Nov 2, 2026. Shares held after the trade: 2,443 (-50.0%).
Gen Digital Head of Products and Portfolio Travis Michael Witteveen Sells $892K of Stock
Travis Michael Witteveen, Head of Products and Portfolio, sold 30,000 shares of Gen Digital Inc. at $29.75 a share, worth $892K in total on Nov 2, 2026. Shares held after the trade: 466,545 (-6.0%).
Allegiant expanded margins despite high fuel costs, leveraging a flexible capacity model and Sun Country integration to maintain full-year EPS guidance of over $6.
Tyler Technologies Insider Daniel M. Pope Sells $277K of Stock
Daniel M. Pope sold 680 shares of Tyler Technologies Inc at $407.56 a share, worth $277K in total on Nov 2, 2026. Shares held after the trade: 2,643 (-20.5%).
Samsara Insider Dominic Phillips Sells $1.23M of Stock
Dominic Phillips sold 29,619 shares of Samsara Inc. at $41.47 a share, worth $1.23M in total on Nov 2, 2026. Shares held after the trade: 1,006,530 (-1.7%).
Nuvation Bio reported strong Iptrosi growth despite a 15% market-wide decline in ROS1 TKI starts, while advancing its IDH1 mutant glioma program toward 2027 data readouts.
Beta Technologies Insider Kyle Clark Sells $689K of Stock
Kyle Clark sold 30,000 shares of Beta Technologies, Inc. at $20.69 to $24.90 a share (average $22.97) in 3 transactions, worth $689K in total between Nov 2, 2026 and Nov 4, 2026. Shares held after the trade: 4,935,936 (-0.2%).
DHI Group shows a tale of two segments: ClearanceJobs is thriving with 18% revenue growth, while Dice faces continued enterprise renewal pressure despite narrowing booking declines.
Pampa Energy CFO Adolfo Fernando Zuberbuhler Buys $207K of Stock
Adolfo Fernando Zuberbuhler, CFO, bought 3,136 shares of Pampa Energy Inc. at $66.11 a share, worth $207K in total on Nov 4, 2026. Shares held after the trade: 2,885.